Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-016749
Filing Date
2015-03-17
Accepted
2015-03-17 16:23:22
Documents
13
Period of Report
2015-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v404062_10q.htm 10-Q 310495
2 EXHIBIT 10.1 v404062_ex10-1.htm EX-10.1 361729
3 EXHIBIT 10.2 v404062_ex10-2.htm EX-10.2 137268
4 EXHIBIT 31.1 v404062_ex31-1.htm EX-31.1 10796
5 EXHIBIT 31.2 v404062_ex31-2.htm EX-31.2 10960
6 EXHIBIT 32.1 v404062_ex32-1.htm EX-32.1 4568
7 EXHIBIT 32.2 v404062_ex32-2.htm EX-32.2 4528
  Complete submission text file 0001144204-15-016749.txt   3361544

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lltp-20150131.xml EX-101.INS 238444
9 XBRL TAXONOMY EXTENSION SCHEMA lltp-20150131.xsd EX-101.SCH 25198
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lltp-20150131_cal.xml EX-101.CAL 33075
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lltp-20150131_def.xml EX-101.DEF 101752
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE lltp-20150131_lab.xml EX-101.LAB 597590
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lltp-20150131_pre.xml EX-101.PRE 202836
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55330 | Film No.: 15707005
SIC: 1000 Metal Mining